SINGLETON J MATTHEW has filed 25 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 3150 shares of Viking Therapeutics, Inc. ($VKTX) on January 02, 2026.
Activity breakdown: 0 open-market purchases and 11 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | A | Common Stock, par value $0.00001 per share | 3150 | $0.00 | 12,650.0000 | 113,036,344 | 33.16% | 0.00% |
| Jan. 2, 2026 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | A | Stock Option (Right to Buy) | 20400 | $0.00 | 20,400.0000 | 113,036,344 | 9999.99% | 0.02% |
| Jan. 2, 2025 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | A | Stock Option (Right to Buy) | 18800 | $0.00 | 18,800.0000 | 0 | 9999.99% | 0.00% |
| Oct. 25, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | M | Stock Option (Right to Buy) | 16000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 25, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | S | Common Stock, par value $0.00001 per share | 16000 | $79.50 | 9,500.0000 | 0 | 62.75% | 0.00% |
| Oct. 25, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | M | Common Stock, par value $0.00001 per share | 16000 | $4.48 | 25,500.0000 | 0 | 168.42% | 0.00% |
| Sept. 20, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | M | Stock Option (Right to Buy) | 10300 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 20, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | M | Common Stock, par value $0.00001 per share | 10300 | $1.19 | 19,800.0000 | 0 | 108.42% | 0.00% |
| Sept. 20, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | S | Common Stock, par value $0.00001 per share | 10300 | $69.50 | 9,500.0000 | 0 | 52.02% | 0.00% |
| Aug. 21, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | M | Stock Option (Right to Buy) | 5700 | $0.00 | 10,300.0000 | 0 | 35.63% | 0.00% |
| Aug. 21, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | M | Common Stock, par value $0.00001 per share | 5700 | $1.19 | 15,200.0000 | 0 | 60.00% | 0.00% |
| Aug. 21, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | S | Common Stock, par value $0.00001 per share | 5700 | $69.72 | 9,500.0000 | 0 | 37.50% | 0.00% |
| Aug. 19, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | S | Common Stock, par value $0.00001 per share | 3047 | $61.13 | 19,953.0000 | 0 | 13.25% | 0.00% |
| Aug. 19, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | S | Common Stock, par value $0.00001 per share | 4509 | $61.86 | 15,444.0000 | 0 | 22.60% | 0.00% |
| Aug. 19, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | S | Common Stock, par value $0.00001 per share | 2055 | $63.15 | 13,389.0000 | 0 | 13.31% | 0.00% |
| Aug. 19, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | S | Common Stock, par value $0.00001 per share | 2388 | $64.10 | 11,001.0000 | 0 | 17.84% | 0.00% |
| Aug. 19, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | S | Common Stock, par value $0.00001 per share | 1501 | $64.88 | 9,500.0000 | 0 | 13.64% | 0.00% |
| Aug. 19, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | M | Stock Option (Right to Buy) | 16000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 19, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | M | Common Stock, par value $0.00001 per share | 16000 | $3.33 | 25,500.0000 | 0 | 168.42% | 0.00% |
| Aug. 19, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | S | Common Stock, par value $0.00001 per share | 2500 | $60.01 | 23,000.0000 | 0 | 9.80% | 0.00% |
| Aug. 14, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | S | Common Stock, par value $0.00001 per share | 160 | $58.37 | 9,500.0000 | 0 | 1.66% | 0.00% |
| Aug. 14, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | M | Stock Option (Right to Buy) | 20786 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | M | Common Stock, par value $0.00001 per share | 20786 | $8.00 | 30,286.0000 | 0 | 218.80% | 0.00% |
| Aug. 14, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Not found | S | Common Stock, par value $0.00001 per share | 20626 | $57.52 | 9,660.0000 | 0 | 68.10% | 0.00% |
| Jan. 2, 2024 | Viking Therapeutics, Inc. | $VKTX | SINGLETON J MATTHEW | Director | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 0 | 9999.99% | 0.00% |